In 2022, Alexander Schuth, M.D. earned $737.20K in total compensation at Denali Therapeutics Inc., including $500.00K salary and $225.00K bonus. Most recently sold 16,706 shares in Aug 2024. Currently holds stock worth $15.60M. 3+ years at the helm of Denali Therapeutics Inc..
Compensation History
Annual executive compensation data for Alexander Schuth, M.D., including salary, bonuses, and stock awards.
Year
2022
Total Compensation
$737.20K
Salary
$500.00K
Bonus
$225.00K
Other
$12.20K
Salary
$500.00KBoard Justification
The compensation philosophy focuses on pay for performance, aligning executive compensation with the achievement of strategic business goals and shareholder interests.
Bonus
$225.00KBoard Justification
The annual bonus was based on the achievement of corporate goals, with a funding percentage of 100% of target due to meeting 75% of the goals set for 2022.
Other Compensation
$12.20KBoard Justification
Other compensation includes employer 401(k) matching contributions.
Restricted Stock
Board Justification
No stock was vested in 2022 as the focus was on options and RSUs granted in previous years.
Performance Metrics
The performance metrics included achieving corporate goals related to product development and strategic initiatives.
Alexander Schuth, M.D.
CEO of Denali Therapeutics Inc.
Sector of Economy
Healthcare
CEO of Denali Therapeutics Inc. for
3 years 7 months (May 2022 - Present)
Previous Experience
Unknown
Other Denali Therapeutics Inc. CEOs
Holdings
Track Alexander Schuth, M.D.'s stock holdings and portfolio value over time.
Total Stock Sold
$17.25M
$17.25M
421,233 DNLI shares
What if they kept their stock?
If Alexander Schuth, M.D. didn't sell their stock, today they would have:
Extra DNLI421,233 shares worth $8.41M.
This is -51.25% and $8.84M less than what they got when they sold the stock.
Insider Trading
Alexander Schuth, M.D.'s recent stock transactions, purchases, and sales filed with the SEC.
$401.56K
DNLI at $24.04/share
Aug 20, 2024
Sale
$52.01K
DNLI at $22.89/share
Aug 13, 2024
Sale
$399.20K
DNLI at $17.48/share
Feb 13, 2024
Sale
$193.76K
DNLI at $19.43/share
Jan 5, 2024
Sale
53,720 shares
DNLI
Jan 3, 2024
Received
$58.43K
DNLI at $23.17/share
Aug 23, 2023
Sale
$55.98K
DNLI at $22.59/share
Aug 21, 2023
Sale
$65.61K
DNLI at $23.67/share
Aug 14, 2023
Sale
$68.99K
DNLI at $24.18/share
Aug 10, 2023
Sale
$587.22K
DNLI at $29.81/share
Jul 17, 2023
Sale
Rivals
Compare Alexander Schuth, M.D. with competitor CEOs and industry peers.